Sign in

NCT06892561Active, not recruiting

Phase-Aligned Atrial Fibrillation Mapping

Atrial Fibrillation Mapping Using Phase-Aligned Spectral Filtering for Decomposing Spatiotemporal Dynamics

Source: ClinicalTrials.gov · Last updated 1 Jul 2026

Brief summary (registry, in English)

Cardiac arrhythmia in the upper chamber of the heart (atrial fibrillation) can be cured by burning. Physicians burn very small pieces of abnormal tissue. It is important to know where to burn. The investigators propose a new way to find out where to burn. The investigators will use a new way to analyze electrical signals inside the heart and build a new electric map. The study may lead to the development of new technology. In the future, novel technology may increase the success rate and the number of cured atrial fibrillation patients. This study is a retrospective study of data collected during routine clinical care: atrial fibrillation ablations. The investigators will compare intracardiac electrograms and atrial activation maps in patients who had successful ablation outcomes (no recurrence within 1 year) and those who experienced a recurrence of arrhythmia within 1 year after the procedure.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
336 (actual)
First submitted
19 Mar 2025
Start date
16 Aug 2023
Primary completion date
31 Mar 2027
Lead sponsor
Larisa Tereshchenko, MD, PhD
NCT number
NCT06892561

What you commit to

  • Study type: Observational
  • Participants enrolled: 336
  • From 16 Aug 2023 to the primary completion date, 31 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Familial AF, AF as a syndrome in rare diseases (cardiomyopathies / WPW/ channelopathies).

Other

  • Missing data of exposure (AF ablation map), outcome (definition of cases and controls), or covariates

Who the study is looking for

  • Records of patients with persistent AF who underwent pulmonary vein isolation (PVI) with any additional AF ablation strategy with available stored digital AF mapping data. Persistent AF is defined as AF lasting more than 7 days.
  • One/First AF ablation procedure (no prior atrial ablation procedures)
  • Documented complete pulmonary vein isolation at the end of the ablation
  • Available uniform, high-quality (as described below) clinical data required to detect AF recurrence during ≥ 1 year after ablation, and/or ECG monitoring (implantable loop recording or repeated long-term ECG monitoring via ECG patch or similar)

Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Cleveland Clinic
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.